Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Cecilie Bendigtsen Schirmer"'
Autor:
Harald Hugenschmidt, Knut Jørgen Labori, Cathrine Brunborg, Caroline Sophie Verbeke, Lars Thomas Seeberg, Cecilie Bendigtsen Schirmer, Anne Renolen, Elin Borgen, Bjørn Naume, Gro Wiedswang
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background Pancreatic and periampullary carcinoma are aggressive tumours where preoperative assessment is challenging. Disseminated tumour cells (DTC) in the bone marrow (BM) are associated with impaired prognosis in a variety of epithelial
Externí odkaz:
https://doaj.org/article/ef0ed3fa93b44b7a976b0c58e4e797b3
Autor:
Elin Borgen, Anne Renolen, Lars Thomas Seeberg, Cecilie Bendigtsen Schirmer, Cathrine Brunborg, Caroline S. Verbeke, Harald Hugenschmidt, Gro Wiedswang, Bjørn Naume, Knut Jørgen Labori
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
BMC Cancer
BMC Cancer
Background Pancreatic and periampullary carcinoma are aggressive tumours where preoperative assessment is challenging. Disseminated tumour cells (DTC) in the bone marrow (BM) are associated with impaired prognosis in a variety of epithelial cancers.
Autor:
Cathrine Brunborg, Gro Wiedswang, Bjørn Naume, Cecilie Bendigtsen Schirmer, Bjørn Atle Bjørnbeth, Harald Hugenschmidt, Kristoffer Watten Brudvik, Elin Borgen, Anne Renolen, Anne Waage, Lars Thomas Seeberg
Publikováno v:
Annals of Surgical Oncology. 22:4029-4037
The presence of circulating tumor cells (CTCs) is negatively associated with survival after resection of colorectal liver metastases (CLM). The current study aimed to determine the prognostic value of CTCs and disseminated tumor cells (DTCs) at the t
Autor:
I Stav, Erik Wist, Elin Borgen, Randi R. Mathiesen, Olav Engebråten, Cecilie Bendigtsen Schirmer, Bjørn Naume, Anna Barbro Sætersdal, MW Fagerland, Anne Fangberget
Publikováno v:
Cancer Research. 73:P1-08
Background: Results from studies with bevacizumab in addition to traditional neoadjuvant therapy (NAT) indicate a need for predictive biomarkers. As a sub-study of the NeoAva study (a neoadjuvant study), the aim was to investigate the potential assoc
Autor:
Jahn M. Nesland, Cecilie Bendigtsen Schirmer, Elin Borgen, Karl Erik Giercksky, Anne Renolen, Ellen Schlichting, Bjørn Naume, Marit Synnestvedt
Publikováno v:
Breast Cancer Research and Treatment. 138:485-497
Detection of disseminated tumour cells (DTCs) in bone marrow by immunocytochemistry (ICC) includes morphological evaluation of cytokeratin immunopositive cells. The aim of this study was to disclose the prognostic significance of different morphologi
Autor:
Christian Kersten, L Vindi, Jahn M. Nesland, Marit Synnestvedt, K Weyde, I Mjaaland, Erik Wist, Terje Risberg, Gro Wiedswang, Bjørn Naume, Elin Borgen, Cecilie Bendigtsen Schirmer
Publikováno v:
Cancer Research. 71:P5-18
Introduction: Detection of disseminated tumor cells (DTC) after completion of systemic adjuvant treatment is a strong predictor of early systemic relapse and death. This analysis can discover early failure of a chosen adjuvant systemic treatment. In
Autor:
Gro Wiedswang, Bjørn Naume, Cecilie Bendigtsen Schirmer, Elin Borgen, Jahn M. Nesland, Rolf Kåresen, Gunnar Kvalheim
Publikováno v:
International Journal of Cancer. 118:2013-2019
Immunocytochemical (ICC) detection of disseminated tumor cells (DTC) in bone marrow (BM) in early breast cancer is an independent prognostic factor. The significance of circulating tumor cells (CTC) in peripheral blood (PB) needs further exploration
Autor:
Elin Borgen, Jahn M. Nesland, Bjørn Naume, Cecilie Bendigtsen Schirmer, Marit Synnestvedt, Ellen Schlichting
Publikováno v:
Cancer Research. 71:P4-06
Introduction: Morphological evaluation increases the specificity of immunocytochemical analysis (ICC) of disseminated tumor cells (DTC) in bone marrow (BM). In the Oslo1 cohort of primary breast cancer (BC) patients (pts), ICC-positive cells detected
Autor:
Erik Wist, Elin Borgen, Anna Barbro Sætersdal, Christian Kersten, Ragnhild Sørum Falk, H. Sommer, Terje Risberg, Gro Wiedswang, Bjørn Naume, Ingvil Mjaaland, Maria Christine Rypdal, Cecilie Bendigtsen Schirmer, Kjetil Weyde, Lise Vindi, Marit Synnestvedt
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(34)
Purpose The presence of disseminated tumor cells (DTCs) in bone marrow (BM) predicts survival in early breast cancer. This study explores the use of DTCs for identification of patients insufficiently treated with adjuvant therapy so they can be offer
Autor:
Christian Kersten, Marit Synnestvedt, Lise Vindi, Cecilie Bendigtsen Schirmer, Ingvil Mjaaland, Kjetil Weyde, Elin Borgen, Terje Risberg, Gro Wiedswang, Bjørn Naume, Jahn M. Nesland, Erik Wist
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 616 (2012)
BMC Cancer
BMC Cancer
Background Presence of disseminated tumor cells (DTCs) in bone marrow (BM) after completion of systemic adjuvant treatment predicts reduced survival in breast cancer. The present study explores the use of DTCs to identify adjuvant insufficiently trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c13bf45d8cd660c70e8d7a18884b58db
https://hdl.handle.net/10037/25013
https://hdl.handle.net/10037/25013